No Data
No Data
5 Stocks at the Forefront of S&P 500 ETF's Latest Rally
BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024
BIO-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT)
Bio-Techne | 10-Q: Quarterly report
Argus Adjusts Price Target on Bio-Techne to $95 From $90, Keeps Buy Rating
Bio-Techne (TECH) has an average rating of buy and price targets ranging from $65 to $95, according to analysts polled by Capital IQ.
Which Large-Cap Stocks Are Winning This Earnings Season? 15 Stocks To Watch (April 28-May 4, 2024)
These large-cap stocks were the best performers in the last week amid earnings season. Are they in your portfolio?
No Data